Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

NCT05032859 PHASE3 COMPLETED Results posted

This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.

Details

Lead sponsor	Organon and Co
Phase	PHASE3
Status	COMPLETED
Enrolment	406
Start date	Thu Sep 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Feb 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Atopic Dermatitis

Interventions

• tapinarof cream, 1%
• vehicle cream

Countries

Canada, United States